![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 5
2021
Matasar, Matthew J.; Dreyling, Martin; Leppa, Sirpa; Santoro, Armando; Pedersen, Michael; Buvaylo, Viktoriya; Fletcher, Monique; Childs, Barrett H. und Zinzani, Pier Luigi
(2021):
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
In: Clinical Lymphoma Myeloma & Leukemia, Bd. 21, Nr. 11, E886-E894
Panayiotidis, Panayiotis; Follows, George A.; Mollica, Luigina; Nagler, Arnon; Ozcan, Muhit; Santoro, Armando; Stevens, Don; Trevarthen, David; Hiemeyer, Florian; Garcia-Vargas, Jose; Childs, Barrett H.; Zinzani, Pier Luigi und Dreyling, Martin
(2021):
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.
In: Blood Advances, Bd. 5, Nr. 3: S. 823-828
2020
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Liana; Hiemeyer, Florian; Miriyala, Ashok; Garcia‐Vargas, Jose; Childs, Barrett H. und Zinzani, Pier Luigi
(2020):
Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study.
In: American Journal of Hematology, Bd. 95, Nr. 4: S. 362-371
[PDF, 1MB]
2017
Laethem, Jean-Luc Van; Riess, Hanno; Jassem, Jacek; Haas, Michael; Martens, Uwe M.; Weekes, Colin; Peeters, Marc; Ross, Paul; Bridgewater, John; Melichar, Bohuslav; Cascinu, Stefano; Saramak, Piotr; Michl, Patrick; Brummelen, David Van; Zaniboni, Alberto; Schmiegel, Wollf; Dueland, Svein; Giurescu, Marius; Garosi, Vittorio L.; Roth, Katrin; Schulz, Anke; Seidel, Henrik; Rajagopalan, Prabhu; Teufel, Michael und Childs, Barrett H.
(2017):
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
In: Targeted Oncology, Bd. 12, Nr. 1: S. 97-109
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George A.; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Panayiotidis, Panayiotis; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Giurescu, Marius; Cupit, Lisa; Liu, Li; Köchert, Karl; Seidel, Henrik; Pena, Carol; Yin, Shuxin; Hiemeyer, Florian; Garcia-Vargas, Jose; Childs, Barrett H. und Zinzani, Pier Luigi
(2017):
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.
In: Journal of Clinical Oncology, Bd. 35, Nr. 35: S. 3898-3910